Results 111 to 120 of about 1,042 (177)

Psychometric Validation of the Subject Sleep Diary in Patients with Moderate-to-Severe Atopic Dermatitis

Dermatology and Therapy
Introduction A subject sleep diary (SSD) capturing 14 sleep parameters was developed to assess daily fluctuations in atopic dermatitis (AD)-associated sleep disturbance.
Jonathan I. Silverberg, Danielle N. Rodriguez, Carla Dias-Barbosa, Dina Filipenko, Liliana Ulianov, Christophe Piketty, Jorge Puelles   +6 more
doaj   +1 more source

Moderate to severe atopic dermatitis in children: focus on systemic Th2 cytokine receptor antagonists and Janus kinase inhibitors [PDF]

Atopic dermatitis (AD) is a lifelong disease that markedly impairs quality of life. AD is considered a starting point of the “atopic march,” which begins at a young age and may progress to systemic allergic diseases.
Jeong Hee Kim, Mona Salem Samra
core   +1 more source

Concurrent Nemolizumab-Induced Cutaneous Adverse Events and Asthma Exacerbation in a Patient With Prurigo Nodularis With Resolution of Both Conditions After Switching to Dupilumab. [PDF]

Cureus
Mima Y, Yamamoto M, Iozumi K.
europepmc   +1 more source

Atopic dermatitis : current state of research on biological treatment [PDF]

, 2020

core  

Real-World, Single-Center Analysis of Cutaneous Adverse Events with Nemolizumab: Toward Safer and More Effective Use. [PDF]

J Clin Med
Sugiyama A, Nakahara T, Kojima K, Nishie H, Nishimura M, Hiramoto T.   +5 more
europepmc   +1 more source

Interferon Regulatory Factor 4 amplifies Th2 responses through inhibition of Il31 expression [PDF]

Th2 cells are specialized to control helminths and other parasites. The protective response induced by Th2 cells, known as the type 2 immune response, is driven by their secretion of the canonical cytokines IL-4, IL-5, and IL-13.
Munoz Sandoval, Priscila
core  

Real-World Evidence Demonstrating Nemolizumab's Rapid Efficacy in Recalcitrant Uremic Pruritus. [PDF]

Cureus
Dalisay H, Segabandi H, Valle K, Tinker D.   +3 more
europepmc   +1 more source

Correction: Safety and efficacy of nemolizumab for patients with pruritus: a systematic review and meta-regression analysis of randomized controlled trial

Frontiers in Immunology
Junqin Liang, Fengxia Hu, Maoli Dan, Yingbing Sang, Kailibinuer Abulikemu, Qian Wang, Yongzhen Hong, Xiaojing Kang   +7 more
doaj   +1 more source

Living network meta-analysis to compare nemolizumab against other available targeted systemic treatments for atopic dermatitis. [PDF]

Br J Dermatol
Drucker AM, Walwyn C, Chu C, Yiu ZZN, Rochwerg B, Di Giorgio S, Arents BWM, Mohan T, Burton T, Spuls PI, Schmitt J, Prieto-Merino D, Flohr C.   +12 more
europepmc   +1 more source

The Visualization of Nocturnal Scratching Behavior in Pediatric Atopic Dermatitis: Facilitating Shared Decision-Making and Assessing the Efficacy of Treatment. [PDF]

Cureus
Sugiyama A, Matsuzaki H, Motomura C, Hiramoto T, Nakahara T.   +4 more
europepmc   +1 more source